09:03 EST Lexeo Therapeutics (LXEO) files to sell 1.25M shares of common stock for holders
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LXEO:
- Lexeo Therapeutics reports Q3 EPS (33c), consensus (44c)
- Lexeo Therapeutics selloff looks ‘highly unwarranted,’ says H.C. Wainwright
- Lexeo Therapeutics Advances Study on Friedreich Ataxia-Associated Cardiomyopathy
- Lexeo Therapeutics Advances Gene Therapy Study for Genetic Heart Condition
- Lexeo Therapeutics Advances Research in Genetic Cardiomyopathy with New Study Update